Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Keith McBurnett, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentPsychiatry
    Address401 Parnassus Ave, LangPorter
    San Francisco CA 94143
    Phone415-476-7892
    vCardDownload vCard

      Collapse ORNG Applications 
      Collapse Websites
      Collapse NIH Awarded Grants
      Collapse Global Health

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Cutler AJ, Brams M, Bukstein O, Mattingly G, McBurnett K, White C, Rubin J. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2014 Oct; 53(10):1092-101.
        View in: PubMed
      2. Findling RL, McBurnett K, White C, Youcha S. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014 Jun; 24(5):245-52.
        View in: PubMed
      3. Villodas MT, McBurnett K, Kaiser N, Rooney M, Pfiffner LJ. Additive effects of parent adherence on social and behavioral outcomes of a collaborative school-home behavioral intervention for ADHD. Child Psychiatry Hum Dev. 2014 Jun; 45(3):348-60.
        View in: PubMed
      4. Pfiffner LJ, Hinshaw SP, Owens E, Zalecki C, Kaiser NM, Villodas M, McBurnett K. A two-site randomized clinical trial of integrated psychosocial treatment for ADHD-inattentive type. J Consult Clin Psychol. 2014 Dec; 82(6):1115-27.
        View in: PubMed
      5. Burns GL, de Moura MA, Beauchaine TP, McBurnett K. Bifactor latent structure of ADHD/ODD symptoms: predictions of dual-pathway/trait-impulsivity etiological models of ADHD. J Child Psychol Psychiatry. 2014 Apr; 55(4):393-401.
        View in: PubMed
      6. Lee S, Burns GL, Snell J, McBurnett K. Validity of the sluggish cognitive tempo symptom dimension in children: sluggish cognitive tempo and ADHD-inattention as distinct symptom dimensions. J Abnorm Child Psychol. 2014 Jan; 42(1):7-19.
        View in: PubMed
      7. McBurnett K, Villodas M, Burns GL, Hinshaw SP, Beaulieu A, Pfiffner LJ. Structure and validity of sluggish cognitive tempo using an expanded item pool in children with attention-deficit/hyperactivity disorder. J Abnorm Child Psychol. 2014 Jan; 42(1):37-48.
        View in: PubMed
      8. Becker SP, Marshall SA, McBurnett K. Sluggish cognitive tempo in abnormal child psychology: an historical overview and introduction to the special section. J Abnorm Child Psychol. 2014 Jan; 42(1):1-6.
        View in: PubMed
      9. Wietecha L, Williams D, Shaywitz S, Shaywitz B, Hooper SR, Wigal SB, Dunn D, McBurnett K. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. J Child Adolesc Psychopharmacol. 2013 Nov; 23(9):605-13.
        View in: PubMed PMC3842866
      10. Faraone SV, McBurnett K, Sallee FR, Steeber J, López FA. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents. Clin Ther. 2013 Nov; 35(11):1778-93.
        View in: PubMed
      11. Becker SP, McBurnett K, Hinshaw SP, Pfiffner LJ. Negative social preference in relation to internalizing symptoms among children with ADHD predominantly inattentive type: girls fare worse than boys. J Clin Child Adolesc Psychol. 2013; 42(6):784-95.
        View in: PubMed
      12. McBurnett K, Swetye M, Muhr H, Hendren RL. Pharmacotherapy of inattention and ADHD in adolescents. Adolesc Med State Art Rev. 2013 Aug; 24(2):391-405, viii.
        View in: PubMed
      13. Pfiffner LJ, Villodas M, Kaiser N, Rooney M, McBurnett K. Educational outcomes of a collaborative school-home behavioral intervention for ADHD. Sch Psychol Q. 2013 Mar; 28(1):25-36.
        View in: PubMed
      14. Villodas MT, Pfiffner LJ, McBurnett K. Prevention of serious conduct problems in youth with attention deficit/hyperactivity disorder. Expert Rev Neurother. 2012 Oct; 12(10):1253-63.
        View in: PubMed
      15. Schweitzer JB, McBurnett K. New directions for therapeutics in ADHD. Neurotherapeutics. 2012 Jul; 9(3):487-9.
        View in: PubMed PMC3441924
      16. Bauermeister JJ, Barkley RA, Bauermeister JA, Martínez JV, McBurnett K. Validity of the sluggish cognitive tempo, inattention, and hyperactivity symptom dimensions: neuropsychological and psychosocial correlates. J Abnorm Child Psychol. 2012 Jul; 40(5):683-97.
        View in: PubMed
      17. Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, Loo SK, Carlson CL, McBurnett K, Lahey BB. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol. 2012 Nov; 121(4):991-1010.
        View in: PubMed
      18. McBurnett K, Starr HL. OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder. Expert Opin Pharmacother. 2011 Feb; 12(2):315-24.
        View in: PubMed
      19. Connor DF, Steeber J, McBurnett K. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 2010 Jun; 31(5):427-40.
        View in: PubMed
      20. Kaiser NM, McBurnett K, Pfiffner LJ. Child ADHD severity and positive and negative parenting as predictors of child social functioning: evaluation of three theoretical models. J Atten Disord. 2011 Apr; 15(3):193-203.
        View in: PubMed
      21. McBurnett K, Pfiffner LJ. Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders. Postgrad Med. 2009 Nov; 121(6):158-65.
        View in: PubMed
      22. Huang-Pollock CL, Mikami AY, Pfiffner L, McBurnett K. Can executive functions explain the relationship between Attention Deficit Hyperactivity Disorder and social adjustment? J Abnorm Child Psychol. 2009 Jul; 37(5):679-91.
        View in: PubMed
      23. Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008 Dec; 13(12):1047-55.
        View in: PubMed
      24. Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008 Jan; 121(1):e73-84.
        View in: PubMed
      25. Arnold LE, Amato A, Bozzolo H, Hollway J, Cook A, Ramadan Y, Crowl L, Zhang D, Thompson S, Testa G, Kliewer V, Wigal T, McBurnett K, Manos M. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol. 2007 Dec; 17(6):791-802.
        View in: PubMed
      26. Pfiffner LJ, Yee Mikami A, Huang-Pollock C, Easterlin B, Zalecki C, McBurnett K. A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1041-50.
        View in: PubMed
      27. Huang-Pollock CL, Mikami AY, Pfiffner L, McBurnett K. ADHD subtype differences in motivational responsivity but not inhibitory control: evidence from a reward-based variation of the stop signal paradigm. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):127-36.
        View in: PubMed
      28. Mikami AY, Huang-Pollock CL, Pfiffner LJ, McBurnett K, Hangai D. Social skills differences among attention-deficit/hyperactivity disorder types in a chat room assessment task. J Abnorm Child Psychol. 2007 Aug; 35(4):509-21.
        View in: PubMed
      29. Pfiffner LJ, McBurnett K. Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol. 2006 Oct; 34(5):725-35.
        View in: PubMed
      30. McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):351-6.
        View in: PubMed
      31. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006 Jan; 160(1):82-90.
        View in: PubMed
      32. Pfiffner LJ, McBurnett K, Rathouz PJ, Judice S. Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol. 2005 Oct; 33(5):551-63.
        View in: PubMed
      33. Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2005 Oct; 44(10):1015-23.
        View in: PubMed
      34. McBurnett K, Raine A, Stouthamer-Loeber M, Loeber R, Kumar AM, Kumar M, Lahey BB. Mood and hormone responses to psychological challenge in adolescent males with conduct problems. Biol Psychiatry. 2005 May 15; 57(10):1109-16.
        View in: PubMed
      35. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, Cho SC, Seo DH, Bae MO, So YK, Noh JS, Koh YJ, McBurnett K, Leventhal B. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K). Yonsei Med J. 2004 Feb 29; 45(1):81-9.
        View in: PubMed
      36. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):424-33.
        View in: PubMed
      37. Lahey BB, Loeber R, Burke J, Rathouz PJ, McBurnett K. Waxing and waning in concert: dynamic comorbidity of conduct disorder with other disruptive and emotional problems over 7 years among clinic-referred boys. J Abnorm Psychol. 2002 Nov; 111(4):556-67.
        View in: PubMed
      38. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001 Oct; 108(4):883-92.
        View in: PubMed
      39. Pfiffner LJ, McBurnett K, Rathouz PJ. Father absence and familial antisocial characteristics. J Abnorm Child Psychol. 2001 Oct; 29(5):357-67.
        View in: PubMed
      40. McBurnett K, Kerckhoff C, Capasso L, Pfiffner LJ, Rathouz PJ, McCord M, Harris SM. Antisocial personality, substance abuse, and exposure to parental violence in males referred for domestic violence. Violence Vict. 2001 Oct; 16(5):491-506.
        View in: PubMed
      41. McBurnett K, Pfiffner LJ, Frick PJ. Symptom properties as a function of ADHD type: an argument for continued study of sluggish cognitive tempo. J Abnorm Child Psychol. 2001 Jun; 29(3):207-13.
        View in: PubMed
      42. Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM, Simpson S, Shapiro C, Bukstein O, Baron-Myak C, McBurnett K. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol. 2000 Dec; 28(6):507-25.
        View in: PubMed
      43. Pfiffner LJ, Calzada E, McBurnett K. Interventions to enhance social competence. Child Adolesc Psychiatr Clin N Am. 2000 Jul; 9(3):689-709, x.
        View in: PubMed
      44. Beebe DW, Pfiffner LJ, McBurnett K. Evaluation of the validity of the Wechsler Intelligence Scale for Children--Third Edition comprehension and picture arrangement subtests as measures of social intelligence. Psychol Assess. 2000 Mar; 12(1):97-101.
        View in: PubMed
      45. Loeber R, Green SM, Lahey BB, Frick PJ, McBurnett K. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000 Mar; 3(1):37-60.
        View in: PubMed
      46. McBurnett K, Lahey BB, Rathouz PJ, Loeber R. Low salivary cortisol and persistent aggression in boys referred for disruptive behavior. Arch Gen Psychiatry. 2000 Jan; 57(1):38-43.
        View in: PubMed
      47. Pfiffner LJ, McBurnett K, Lahey BB, Loeber R, Green S, Frick PJ, Rathouz PJ. Association of parental psychopathology to the comorbid disorders of boys with attention deficit-hyperactivity disorder. J Consult Clin Psychol. 1999 Dec; 67(6):881-93.
        View in: PubMed
      48. Lahey BB, Waldman ID, McBurnett K. Annotation: the development of antisocial behavior: an integrative causal model. J Child Psychol Psychiatry. 1999 Jul; 40(5):669-82.
        View in: PubMed
      49. McBurnett K, Pfiffner LJ, Willcutt E, Tamm L, Lerner M, Ottolini YL, Furman MB. Experimental cross-validation of DSM-IV types of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999 Jan; 38(1):17-24.
        View in: PubMed
      50. Lahey BB, Loeber R, Quay HC, Applegate B, Shaffer D, Waldman I, Hart EL, McBurnett K, Frick PJ, Jensen PS, Dulcan MK, Canino G, Bird HR. Validity of DSM-IV subtypes of conduct disorder based on age of onset. J Am Acad Child Adolesc Psychiatry. 1998 Apr; 37(4):435-42.
        View in: PubMed
      51. Pfiffner LJ, McBurnett K. Social skills training with parent generalization: treatment effects for children with attention deficit disorder. J Consult Clin Psychol. 1997 Oct; 65(5):749-57.
        View in: PubMed
      52. Applegate B, Lahey BB, Hart EL, Biederman J, Hynd GW, Barkley RA, Ollendick T, Frick PJ, Greenhill L, McBurnett K, Newcorn JH, Kerdyk L, Garfinkel B, Waldman I, Shaffer D. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry. 1997 Sep; 36(9):1211-21.
        View in: PubMed
      53. McBurnett K, Lahey BB, Capasso L, Loeber R. Aggressive symptoms and salivary cortisol in clinic-referred boys with conduct disorder. Ann N Y Acad Sci. 1996 Sep 20; 794:169-78.
        View in: PubMed
      54. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994 Nov; 151(11):1673-85.
        View in: PubMed
      55. Frick PJ, O'Brien BS, Wootton JM, McBurnett K. Psychopathy and conduct problems in children. J Abnorm Psychol. 1994 Nov; 103(4):700-7.
        View in: PubMed
      56. Lahey BB, Applegate B, Barkley RA, Garfinkel B, McBurnett K, Kerdyk L, Greenhill L, Hynd GW, Frick PJ, Newcorn J, et al. DSM-IV field trials for oppositional defiant disorder and conduct disorder in children and adolescents. Am J Psychiatry. 1994 Aug; 151(8):1163-71.
        View in: PubMed
      57. McBurnett K, Lahey BB. Psychophysiological and neuroendocrine correlates of conduct disorder and antisocial behavior in children and adolescents. Prog Exp Pers Psychopathol Res. 1994; 199-231.
        View in: PubMed
      58. McBurnett K, Pfiffner LJ. ADHD and LD. J Learn Disabil. 1991 May; 24(5):258-60.
        View in: PubMed
      59. Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G. Effects of stimulant medication on learning in children with ADHD. J Learn Disabil. 1991 Apr; 24(4):219-30, 255.
        View in: PubMed
      60. Walker JL, Lahey BB, Russo MF, Frick PJ, Christ MA, McBurnett K, Loeber R, Stouthamer-Loeber M, Green SM. Anxiety, inhibition, and conduct disorder in children: I. Relations to social impairment. J Am Acad Child Adolesc Psychiatry. 1991 Mar; 30(2):187-91.
        View in: PubMed
      61. McBurnett K, Lahey BB, Frick PJ, Risch C, Loeber R, Hart EL, Christ MA, Hanson KS. Anxiety, inhibition, and conduct disorder in children: II. Relation to salivary cortisol. J Am Acad Child Adolesc Psychiatry. 1991 Mar; 30(2):192-6.
        View in: PubMed
      62. Christ MA, Lahey BB, Frick PJ, Russo MF, McBurnett K, Loeber R, Stouthamer-Loeber M, Green S. Serious conduct problems in the children of adolescent mothers: disentangling confounded correlations. J Consult Clin Psychol. 1990 Dec; 58(6):840-4.
        View in: PubMed
      63. Pelham WE, McBurnett K, Harper GW, Milich R, Murphy DA, Clinton J, Thiele C. Methylphenidate and baseball playing in ADHD children: who's on first? J Consult Clin Psychol. 1990 Feb; 58(1):130-3.
        View in: PubMed
      64. Lahey BB, Hartdagen SE, Frick PJ, McBurnett K, Connor R, Hynd GW. Conduct disorder: parsing the confounded relation to parental divorce and antisocial personality. J Abnorm Psychol. 1988 Aug; 97(3):334-7.
        View in: PubMed
      65. Lahey BB, Piacentini JC, McBurnett K, Stone P, Hartdagen S, Hynd G. Psychopathology in the parents of children with conduct disorder and hyperactivity. J Am Acad Child Adolesc Psychiatry. 1988 Mar; 27(2):163-70.
        View in: PubMed
      Back to TOP